Event description

WEBINAR  February  6, 2021

9:30-11:00 A.M., E.T.

Ultrasound-guided thermal ablation treatments are nowadays playing an increasingly important role in the multidisciplinary management of patients with benign nodular thyroid disease, and are increasingly offered as a first therapeutic option. This trend is rising even more in the last months in which, due to COVID-19 pandemic, clinicians are re-defining their clinical practice considering ambulatory treatments as a feasible alternative to the surgical approach due to the need of reserving beds and staff for emergency COVID-19 patients. ModìLite treatment perfectly fits these needs, allowing simple and fast procedures performed in an outpatient setting and without the need of anaesthesia,  for the micro-invasive treatment of Benign Thyroid Nodules (BTNs). During this webinar, ModìLite treatment will be presented, with particular attention to the indications, the results reported in the literature and possible future applications.

 

Chairmen: Stefano Spiezia, Ralph P. Tufano

Chairmen: Stefano Spiezia, Ralph P. Tufano

09:30-09:50   ModìLite technique presentation, treatment indications &
                         functional results     
                         Stefano Spiezia

09:50-10:10    ModìLite clinical evidence: international guidelines evidence,
                         literature review and long term results   
                         Enrico Papini

10:10-10:30     First experience with ModìLite treatment for BTN in USA       
                         Augustin A. Andrade

10:30-10:50     Comments and discussion    
                          Catherine Sinclair, Timothy Huber

10:50-11:00      Question time

REGISTER NOW

Attachments
PROGRAM